Why the study?
The study was conducted to assess the possibilities of quantitative MRI in the diagnosis and monitoring of rhabdomyolysis of various etiologies.
Does quantitative MRI with T1, T2, and T2 relaxometry improve the diagnosis and monitoring of rhabdomyolysis in patients with clinical manifestations?
Does quantitative MRI with T1, T2, and T2 relaxometry improve the diagnosis and monitoring of rhabdomyolysis in patients with clinical manifestations?
Quantitative MRI with T2 relaxometry provides high sensitivity and specificity for diagnosing rhabdomyolysis and can serve as a non-invasive biomarker for monitoring muscle tissue recovery.
Answers are grounded in this paper and cite their sources.
Supports T2 relaxometry as a noninvasive biomarker in rhabdomyolysis; leaves open prospective validation before clinical adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Emelyantsev et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: